In contrast, both absolute HW and HW/BW ratio were significantly lower in the TY-51469-treated group than in the placebo-treated group, suggesting that chymase inhibition suppressed the progression of cardiac hypertrophy induced by chronic Ang II stimulation. The gene discussed is CMA1; the disease is cardiac hypertrophy.